Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 58.86 million as of August 15, 2025. Its market cap has increased by 190.57% in one year.

Market Cap

58.86M

Enterprise Value

74.71M

Revenue

25.70M

Ranking

n/a

PE Ratio

n/a

Stock Price

5.65

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 58.86M, a decrease of -65.33%. That is a compound annual growth rate of -10.58%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	58.86M	178.73%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	74.69M	-64.39%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.66B
GSK plc	56.72B
Haleon	32.11B
Smith & Nephew	11.74B
ConvaTec Group	4.67B
Hikma Pharmaceuticals	3.96B
Oxford Nanopore Technologies	2.04B
HUTCHMED (China)	2.01B

Market Cap Rankings